InMed Pharmaceuticals (INM) Research & Development (2021 - 2025)
Historic Research & Development for InMed Pharmaceuticals (INM) over the last 5 years, with Q3 2025 value amounting to $581612.0.
- InMed Pharmaceuticals' Research & Development fell 1692.98% to $581612.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 147.71%. This contributed to the annual value of $2.9 million for FY2025, which is 1130.05% down from last year.
- Per InMed Pharmaceuticals' latest filing, its Research & Development stood at $581612.0 for Q3 2025, which was down 1692.98% from $112720.0 recorded in Q2 2025.
- InMed Pharmaceuticals' Research & Development's 5-year high stood at $2.5 million during Q4 2021, with a 5-year trough of $112720.0 in Q2 2025.
- Over the past 5 years, InMed Pharmaceuticals' median Research & Development value was $878303.0 (recorded in 2023), while the average stood at $1.0 million.
- Per our database at Business Quant, InMed Pharmaceuticals' Research & Development skyrocketed by 7389.02% in 2024 and then crashed by 8289.19% in 2025.
- Over the past 5 years, InMed Pharmaceuticals' Research & Development (Quarter) stood at $2.5 million in 2021, then crashed by 66.44% to $851356.0 in 2022, then dropped by 28.37% to $609791.0 in 2023, then soared by 73.89% to $1.1 million in 2024, then tumbled by 45.15% to $581612.0 in 2025.
- Its Research & Development stands at $581612.0 for Q3 2025, versus $112720.0 for Q2 2025 and $909653.0 for Q1 2025.